Recherche
Résultats 81-90 de 188
-
Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
Science, 20-01-2023, 379, 253-260Article dans une revue scientifique -
Effect of medical staff training on vaccination coverage in outpatients with cancer: An interventional multicenter before-and-after study.
Vaccine: X, 20-01-2023, 13, 100261Article dans une revue scientifiquetexte intégral -
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.
European Society for Medical Oncology, 05-08-2023, 8, 101610Article dans une revue scientifique -
Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.
European Society for Medical Oncology, 15-04-2023, 8, 101202Article dans une revue scientifique -
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European Journal of Cancer, 28-11-2023, 196, 113454Article dans une revue scientifique -
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study.
JMIR mHealth and uHealth, 10-11-2022, 10, e40718Article dans une revue scientifiquetexte intégral -
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
ESMO Open, 02-2021, 6 (1), 100037Article dans une revue scientifiquetexte intégral -
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naïve Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology, 24-10-2020, 16 (2), 289–98Article dans une revue scientifiquetexte intégral -
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on <i>FGFR1</i>/ <i>3</i> mRNA Expression.
Journal of Clinical Oncology, 16-10-2022, JCO2102303Article dans une revue scientifiquetexte intégral -
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma.
Cancers, 17-12-2020, 12 (12), 3647Article dans une revue scientifiquetexte intégral